Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Medicine 2007;12:12; doi:10.1136/ebm.12.1.12
Copyright © 2007 by the BMJ Publishing Group Ltd.

Therapeutics

Review: long acting ß2 adrenoceptor agonists are effective in poorly reversible chronic obstructive pulmonary disease

Appleton S, Poole P, Smith B, et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006(3):CD001104.[Medline]

Q In patients with chronic obstructive pulmonary disease (COPD) and poor reversibility to short acting bronchodilators, how effective are long acting ß2 adrenoceptor agonists (LABAs)?

Clinical impact ratings GP/FP/Primary care *****{star}{star} IM/Ambulatory care ******* Respirology ******{star}

Key Words: adrenergic beta-agonists • albuterol • bronchodilator agents • ethanolamines • lung diseases (obstructive)

The first 150 words of the full text of this article appear below.

METHODS

Formula Data sources: Medline, EMBASE/Excerpta Medica, CINAHL, Cochrane Central Register of Controlled Trials, Cochrane Airways Group Specialised Register (to July 2005), online registries of published and unpublished clinical trials, lists of conference abstracts, and bibliographies of relevant studies.

Formula Study selection and assessment: randomised controlled trials (RCTs) that compared inhaled LABAs (salmeterol or formoterol) given for >=4 weeks with placebo in patients who had stable, moderately severe COPD without asthma; FEV1 <=75% or FEV1/FVC <=70% of predicted value; poor reversibility after short dose short acting ß2 agonist (<=15% reversibility of FEV1 from baseline or as a percentage of predicted normal value); and no infections, exacerbations, or hospital admissions in the past month. Individual study quality was assessed using the 5 point Jadad scale. 23 RCTs (n = 6061, mean age range 58–72 y) met the selection criteria and had Jadad scores between 3 and 5.

Formula Outcomes: lung function (FEV1, . . . [Full text of this article]

Shirin Shafazand, MD, MS, FRCPC

University of Miami, Miller School of Medicine,
Miami, Florida, USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.